NASDAQ$EHTH
eHealth Inc · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
eHealth reported strong first quarter results with total revenue growth and significant year-over-year improvement in profitability metrics and operating cash flow.
eHealth, Inc. announced its financial results for the first quarter ended March 31, 2024, showcasing a 26% increase in total revenue compared to Q1 2023. The company also achieved positive operating cash flow for the trailing twelve-months ended March 31, 2024, exceeding its target.
- Total revenue for Q1 2024 increased by 26% year-over-year to $93.0 million.
- Medicare Advantage approved members increased by 9% to 65,750 compared to Q1 2023.
- GAAP net loss for Q1 2024 improved by $2.9 million year-over-year to $17.0 million.
- Operating cash flow improved by 16% to $70.8 million for the three months ended March 31, 2024.
Headline financials
Revenue & EPS history
eHealth · Revenue · Quarterly
$93M
Revenue by segment
eHealth · $64.7M total across 2 segments · Q3 2023
- Medicare$55.5M+23.0%85.8%
- Employer and Individual$9.2M—14.2%
Forward guidance
eHealth reiterates its full year 2024 guidance, with total revenue expected to be in the range of $450 million to $475 million, GAAP net loss between $(40) million and $(20) million, adjusted EBITDA between $(5) million and $20 million, and operating cash flow between $(15) million and $(5) million.
Tailwinds
- Total revenue is expected to be in the range of $450 million to $475 million.
- GAAP net income (loss) is expected to be in the range of $(40) million to $(20) million.
- Adjusted EBITDA is expected to be in the range of $(5) million to $20 million.
- Operating cash flow is expected to be in the range of $(15) million to $(5) million.
- Mid-point of 2024 guidance reflects approximately 12% year-over-year total revenue growth.
Headwinds
- Actual results may be materially different and are affected by risk factors and uncertainties.
- Guidance includes the expected impact of positive net adjustment revenue in the range of $0 to $15 million.
- GAAP net loss is still expected, although a substantial improvement is anticipated.
- Adjusted EBITDA is still expected to be negative or only slightly positive.
- Operating cash flow is expected to be negative.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2024
-1.0%
Avg return
Earnings day
-1.1%
Avg return
5 days after
+0.6%
Avg return
30 days after
45%
29 / 65 earnings
Positive
+25.2%
Q3 2022
Best reaction
-34.3%
Q2 2014
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +1.5% | -7.1% | -12.7% | |
| Q4 2025 | -30.7% | -17.5% | -32.3% | |
| Q3 2025 | -21.8% | -16.2% | -22.9% | |
| Q1 2025 | +23.2% | +19.2% | -8.1% | |
| Q4 2024 | +3.3% | -5.7% | -28.2% | |
| Q3 2024 | +9.2% | +3.5% | +12.2% | |
| Q2 2024 | -12.8% | -7.7% | -18.8% | |
| Q1 2024 | +12.4% | +8.2% | +9.4% | |
| Q4 2023 | -8.2% | -7.1% | -14.6% | |
| Q3 2023 | -8.5% | -11.7% | +2.1% | |
| Q2 2023 | -0.1% | -1.1% | -14.2% | |
| Q1 2023 | +15.1% | +8.2% | +49.1% | |
| Q4 2022 | -8.4% | +2.5% | +5.4% | |
| Q3 2022 | +25.2% | +27.8% | +47.4% | |
| Q2 2022 | -2.7% | +16.8% | -32.2% | |
| Q1 2022 | +22.5% | +31.1% | +31.1% | |
| Q4 2021 | -16.7% | -25.5% | -20.1% | |
| Q3 2021 | -25.8% | -30.7% | -35.2% | |
| Q2 2021 | -5.9% | -9.3% | -28.6% | |
| Q1 2021 | -0.7% | -5.2% | -8.4% | |
| Q4 2020 | +5.9% | +6.6% | +19.4% | |
| Q3 2020 | -6.8% | -8.2% | -8.7% | |
| Q2 2020 | -31.1% | -36.9% | -40.3% | |
| Q1 2020 | -8.1% | -7.1% | +12.4% | |
| Q4 2019 | -0.6% | -13.7% | -22.3% | |
| Q3 2019 | +0.2% | +10.8% | +39.3% | |
| Q2 2019 | +24.8% | +21.5% | +10.5% | |
| Q1 2019 | +3.7% | -2.0% | +4.3% | |
| Q4 2018 | -3.6% | -7.2% | -4.9% | |
| Q3 2018 | +13.2% | +15.2% | +23.0% | |
| Q2 2018 | -3.6% | -1.2% | +24.6% | |
| Q1 2018 | +17.3% | +21.6% | +31.9% | |
| Q4 2017 | -16.2% | -4.1% | -12.2% | |
| Q3 2017 | +7.0% | +15.3% | +3.5% | |
| Q2 2017 | -5.3% | -8.3% | +23.3% | |
| Q1 2017 | +23.2% | +39.6% | +59.9% | |
| Q4 2016 | +8.9% | +6.3% | +2.5% | |
| Q3 2016 | -31.8% | -30.2% | -5.6% | |
| Q2 2016 | -29.4% | -32.2% | -18.6% | |
| Q1 2016 | +23.2% | — | — | |
| Q4 2015 | +0.7% | — | — | |
| Q3 2015 | -4.2% | — | — | |
| Q2 2015 | +21.4% | — | — | |
| Q1 2015 | +13.5% | — | — | |
| Q4 2014 | -3.6% | — | — | |
| Q3 2014 | +15.4% | — | — | |
| Q2 2014 | -34.3% | — | — | |
| Q1 2014 | -12.3% | — | — | |
| Q4 2013 | -8.5% | — | — | |
| Q3 2013 | +9.6% | — | — | |
| Q2 2013 | -1.8% | — | — | |
| Q1 2013 | +7.3% | — | — | |
| Q4 2012 | -22.8% | — | — | |
| Q3 2012 | +9.5% | — | — | |
| Q4 2011 | -1.1% | — | — | |
| Q2 2012 | +9.7% | — | — | |
| Q1 2011 | +1.0% | — | — | |
| Q1 2012 | +0.6% | — | — | |
| Q4 2009 | -2.5% | — | — | |
| Q3 2010 | -3.1% | — | — | |
| Q3 2011 | -3.1% | — | — | |
| Q4 2010 | -7.0% | — | — | |
| Q2 2011 | -7.0% | — | — | |
| Q2 2010 | -7.0% | — | — | |
| Q1 2010 | +2.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro